Evidence map›Paper›PMID 39233656›Full record

ArticleCephalalgia : an international journal of headache2024

A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache.

Caroline M Kopruszinski, Grace Lee, Laurent K Martin, Kara R Barber, Aubin Moutal, David W Dodick, Edita Navratilova, Frank Porreca

Abstract read
In one paragraph

Article in Cephalalgia : an international journal of headache, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. The therapeutic pipeline in migraine: What does the future hold?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  5. Pathogenic Role of FGFR3 Autoantibodies in Small Fiber Neuropathy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Chronification of migraine sensitizes to CGRP in male and female mice.Cephalalgia : an international journal of headache · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Caroline M KopruszinskiDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.ORCID 0000-0002-5392-5117
Grace LeeDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.
Laurent K MartinDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.
Kara R BarberDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.
Aubin MoutalPharmacology and Physiology, Saint Louis University, St. Louis, MO, USA.
David W DodickDepartment of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Edita NavratilovaDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.
Frank PorrecaDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.ORCID 0000-0002-2267-0617

Funding

PAIN, NOCICEPTION, AND THE AMYGDALAR01NS038261 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Volker Neugebauer, Igor Ponomarev · 1999 to 2026
$8.7M
Brain Circuits of Migraine PainR01NS129552 · NINDS · UNIVERSITY OF ARIZONA · PI Edita Navratilova, Volker Neugebauer · 2022 to 2026
$3.1M
A prolactin-mediated neuroendocrine link between stress-induced latent sensitization and female-selective painR01NS120395 · NINDS · UNIVERSITY OF ARIZONA · PI NAVRATILOVA, EDITA, NEUGEBAUER, VOLKER · 2021 to 2025
$2.3M
NINDS NIH HHS R01 NS038261NINDS NIH HHS R01 NS120395NINDS NIH HHS R01 NS129552
6 · The paper itself

Abstract

backgroundWe wished to explore possible sexual dimorphism in mechanisms sensitizing or activating meningeal nociceptors that can promote the headache phase of migraine.

methodsMale and female C57BL6J mice received either supradural orexin B and an inflammatory mediator cocktail (IM) with migraine-like pain behaviors and photophobia recorded. Expression of orexin 2 receptor (OX2R) in trigeminal ganglion (TG) and phosphorylated extracellular signal-regulated kinases (ERK) levels in trigeminal nucleus caudalis (TNC) were evaluated. Orexin B-induced excitability of TG cells was assessed with patch-clamp electrophysiology. Intranasal delivery of CRISPR/Cas9 plasmids was used to edit the expression of OX2R in the TG.

resultsSupradural orexin B induced migraine-like pain behaviors, photophobia and increased TNC ERK phosphorylation exclusively in males. Blockade of orexin signaling with supradural suvorexant, a dual orexin receptor antagonist, prevented, but did not reverse, migraine-like pain in males induced by supradural IM cocktail. OX2R expression was higher in male TG and orexin B increased TG neuron excitability in males. Intranasal OX2R CRISPR/Cas9 reduced TG receptor expression and orexin B-induced TNC ERK phosphorylation and prevented migraine-like pain induced by supradural orexin B in males.

conclusionsOur studies reveal a male-specific mechanism of TG nociceptor sensitization and migraine-like pain behavior mediated by orexin B/OX2R signaling. Sexually dimorphic mechanisms of trigeminal nociceptor sensitization and activation offer opportunities to improve patient outcomes by considering patient sex and may influence clinical trial design and interpretation.

Indexed as

Mice, Inbred C57BLMigraine DisordersOrexin ReceptorsTrigeminal GanglionAnimalsFemaleMaleMeningesMiceOrexinsSex CharacteristicsOrexin ReceptorsOrexinsmale nociceptorsmigraineorexin Borexin receptor 2Sexual dimorphismtrigeminal system

Identifiers

PMID39233656
PMCPMC12204761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.